王玉鹏，副教授，硕士生导师。研究领域：生物可降解高分子材料、药物制剂在肿瘤及炎症疾病的靶向治疗研究。近五年以第一作者或通讯作者身份在Nature Communications, Advanced Materials，Acta Pharmaceutica Sinica B，Biomaterials，ACS Nano, Nano letters，Journal of Controlled Release等期刊发表20余篇。先后主持了国家自然科学基金青年、面上项目，博士后站中特别资助，广东省自然科学基金面上基金等6项课题。

联系方式

地址：河北省石家庄市南二环东路20号

研究室：williamhill英国中文，william威廉英国，7号楼A221

邮箱：E-mail：yupengwang@hebtu.edu.cn

教育及工作经历

2024.11–至今  williamhill英国中文，william威廉英国，副教授

2019.04–2024.11 南方医科大学，顺德医院/珠江医院，博士后/副研究员

2018.07–2019.01 williamhill英国中文，william威廉英国，讲师

2014.09–2018.06，中国科学院长春应用化学研究所，博士

科研项目

1. 国家自然科学基金面上项目，2024-2027年，48万元，主持，在研

2. 国家自然科学基金青年项目，2020-2022年，25万元，主持，结题

3. 中国博士后基金站中特别资助，2022-2024年, 18万元, 主持，结题

4. 中国博士后基金面上项目，2022-2024年, 8万元, 主持，结题

5. 中国博士后基金面上项目，2020-2021年, 8万元, 主持，结题

6. 广东省自然科学基金面上基金，2024-2026, 15万元，主持，结题

代表性论文：

1. Wei Wang, Fei Li, Wanying Mo, Zining Liu, Juan Xu, Yi Li, Peixian Weng, Zihui Liu, Pingqiang Cai, Shasha He*, Yupeng Wang*, Dongfang Zhou*, Granulomas Immune Landscape-Guided Tuberculosis Sono-Immunotherapy and Recurrence Prevention Using Organic Semiconducting Nano-Immunostimulants, Nature Communications. 2026, Accept. （纳米制剂抗结核治疗）

2. Peiying Huang, Sijin Chen, Xinru Huang, Peixian Weng, Ting Mei, Weimin Wang, Jing Chen, Yupeng Wang*, Dongfang Zhou*, Hydrogel/nano-immunostimulant composite mitigates surgery-exacerbated immunosuppression for durable postsurgical adjuvant treatment of high-propensity lymph node-metastatic tumors. Biomaterials. 2026, 325, 123562.（凝胶制剂肿瘤术后治疗）

3. Tao Li, Min Ouyang, Wei Wang, Sijin Chen, Chengxinqiao Wang, Jiahui Lai, Peixian Weng, Zhenhua Li, Yupeng Wang* and Dongfang Zhou*, Engineering Red Blood Cells for Amplified Tumor Dual-Gas Transfusion Therapy. Advanced Materials. 2025, 2503206.（纳米制剂肿瘤治疗）

4. Shaobing Li, Juntao Lin, Chengxinqiao Wang, Junhan Liu, Yupeng Wang*, Yan Chen*, Dongfang Zhou*, Synergistic metabolic modulation of fibroblast-like synoviocytes via targeted dual prodrug nanoparticles to mitigate rheumatoid arthritis. Acta Pharmaceutica Sinica B 2025, 15(1), 542e556.（纳米制剂类风湿关节炎治疗）

5. Tao Li, Yupeng Wang* and Dongfang Zhou*, Manipulation of protein corona for nanomedicines, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2024, 16, e1982.（抗肿瘤治疗综述）

6. Wei Wang, Wanying Mo, Xue Xiao, Manying Cai, Songfu Feng, Yupeng Wang*, Dongfang Zhou*, Antibiotic-Loaded Lactoferrin Nanoparticles as A Platform for Enhanced Infection Therapy through Targeted Elimination of Intracellular Bacteria, Asian Journal of Pharmaceutical Sciences. 2024, 19, 100926.（纳米制剂抗菌治疗）

7. Wei Wang, Ziwei Hu, Wanying Mo, Min Ouyang, Shihao Lin, Xiang Li, Chengxinqiao Wang, Feng Yu , Yupeng Wang*, Dongfang Zhou*, Ultrastable in-situ silver nanoparticle dressing for effective prevention and treatment of wound infection in emergency, Engineered Regeneration. 2024, 5, 111-123. （敷料制剂抗菌治疗）

8. Yupeng Wang, Lina Wang, Tao Li, Min Ouyang, Hejian Xiong, Dongfang Zhou*, Bimetallic nanoparticles as cascade sensitizing amplifiers for low-dose and robust cancer radio-immunotherapy. Acta Pharmaceutica Sinica B. 2024, 14(4), 1787e1800.（纳米制剂抗肿瘤治疗）

9. Wei Wang, Xiaowen Liu, Yupeng Wang*, Dongfang Zhou*, Lukui Chen*, Application of biomaterials in the treatment of intracerebral hemorrhage, Biomaterials Science. 2024, 12, 4065.（抗脑出血综述）

10. Yupeng Wang#, Yuwei Cong#, Manying Cai, Xiaoling Liang, Lina Wang, Dongfang Zhou*; Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy. Journal of Controlled Release. 2023, 356, 567-579.（纳米制剂抗肿瘤治疗）

11. Libiao Yan#, Siqi Lin#, Lina Wang, Yupeng Wang*, Dongfang Zhou, Qingbing Zeng*; Multifunctional and Multimodality Theranostic Nanomedicine for Enhanced Phototherapy, Journal of materials chemistry. B. 2023, 11, 1808-1817.（纳米制剂抗肿瘤治疗）

12. Yuanxiang Yu#, Sijin Chen, Yupeng Wang*, Dongfang Zhou, and Dehua Wu*. Fighting against Drug-Resistant Tumor by the Induction of Excessive Mitophagy with Transferrin Nanomedicine, Macromolecular Bioscience. 2023, 2300116.（纳米制剂抗肿瘤治疗）

13. Shaobing Li, Wei Sun, Min Ouyang, Bo Yu, Yan Chen*, Yupeng Wang*, Dongfang Zhou*, Hemoglobin-Related Biomaterials and their Applications, Advanced NanoBiomed Research. 2023, 3, 2200103.（纳米药物制剂综述）

14. JunHui Sun#, Xiaoling Liang#, Manying Cai, Libiao Yan, Zhengju Chen, Lei Guo, Li Jing*, Yupeng Wang*, Dongfang Zhou*; Protein-Crowned Micelles for Targeted and Synergistic Tumor Associated Macrophage Reprogramming to Enhance Cancer Treatment. Nano Letters. 2022, 22, 11, 4410–4420.（纳米制剂抗肿瘤治疗）

15. Xiaohui Xiao#, Yupeng Wang#, Jieyao Chen, Peng Qin, Peiyao Chen, Dongfang Zhou*, Yue Pan*; Self-Targeting Platinum(IV) Amphiphilic Prodrug Nano-Assembly as Radiosensitizer for Synergistic and Safe Chemoradiotherapy of Hepatocellular Carcinoma. Biomaterials. 2022, 289, 121793.（纳米制剂抗肿瘤治疗）

16. Yupeng Wang, Jie Yu, Zhijian Luo, Qiankun Shi, Guanglong Liu, Fan Wu, Zhizhang Wang, Yubin Huang*, Dongfang Zhou*, Engineering Endogenous Tumor-Associated Macrophages-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy. Advanced Materials. 2021, 2103497.（纳米制剂肿瘤治疗）

17. Lina Wang, Zejun Liu, Shumei He, Shasha He* and Yupeng Wang*, Fighting against drug-resistant tumors by the inhibition of gamma-glutamyl transferase with supramolecular platinum prodrug nano-assemblies. Journal of materials chemistry. B. 2021, 9, 4587-4595.（纳米制剂抗肿瘤治疗）

18. Yupeng Wang, Zhijian Luo, Dongfang Zhou, Xuefeng Wang, Jianjun Chen*, Shipeng Gong* and Zhiqiang Yu*, Nano-assembly of Ursolic Acid with Platinum Prodrug Overcomes Multiple Deactivation Pathways in Platinum-Resistant Ovarian Cancer. Biomaterials Science. 2021, 9, 4110-4119.（纳米制剂抗肿瘤治疗）

19. Yupeng Wang#, Lesan Yan#, Shasha He, Dongfang Zhou*, Yanxiang Cheng, Xuesi Chen, Xiabin Jing, and Yubin Huang*, A Versatile Method to Prepare Protein Nanoclusters for Drug Delivery. Macromolecular Bioscience. 2018, 18, 1700282.（血液代用品研究）

20. Yupeng Wang, Lina Wang, Bin Li, Yanxiang Cheng, Dongfang Zhou*, Xuesi Chen, Xiabin Jing, and Yubin Huang*; Compact Vesicles Self-Assembled from Binary Graft Copolymers with High Hydrophilic Fraction for Potential Drug/Protein Delivery. ACS Macro Letters. 2017, 6, 1186−1190.（血液代用品研究）